Here are three highlights:
1. Dr. Zoëga will be assuming the position on March 7, 2016.
2. He completed his residency and worked as a spine surgeon and clinical chief at the Sahlgrenska University Hospital. He has also been the CEO of Landspitali University Hospital in Reykjavik which earned him the “CEO of the Year” award in Iceland. Dr. Zoëga also holds positions as chairman of the board of Iceland’s healthcare payer and of the scientific board of the pharmaceutical company Alvotech.
3. GHP is an internationally active healthcare provider that operates specialist clinics in a select number of diagnostic areas through the application of a business model that is unique to the healthcare industry, where leading doctors become partners and shareholders.
More articles on spine:
‘July effect’ not impacting neurosurgery field: 5 findings
Bone Therapeutics adds 4 patients to ALLOB clinical trial: 5 notes
Primary care physicians lead in opioid prescriptions — 5 takeaways
